Copeptin as a promising biomarker of cerebrovascular events: A minireview.

Cerebrovascular events remain a major health issue, and despite significant improvements in diagnosis and treatment in recent years, their high morbidity and mortality mean that increasing attention is now being given to prevention and early predicti…

Preview only. Read the full abstract at the source